Related Experiment Video
Updated: Mar 21, 2026

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
Mirror, mirror on the wall: which microbiomes will help heal them all?
Renuka R Nayak1, Peter J Turnbaugh2
1Department of Microbiology and Immunology, G.W. Hooper Foundation, University of California San Francisco, 513 Parnassus Avenue, San Francisco, CA, 94143, USA.
Individual differences in drug response may stem from the human microbiome, not just genetics. Understanding the microbiome offers new ways to predict treatment success and personalize medicine.
Area of Science:
- Microbiome research
- Pharmacogenomics
- Drug metabolism
Background:
- Patient variability in drug response is a long-standing clinical observation.
- Human genome sequencing aids in understanding drug response but is incomplete.
- The human microbiome is an emerging factor influencing drug efficacy and toxicity.
Discussion:
- Current drug response assessments often overlook the microbiome's role in drug metabolism.
- Microbial metabolism of drugs produces metabolites that alter drug activity, clearance, and toxicity.
- Individual microbiome composition significantly impacts drug response variability.
Key Insights:
- Microbiome-based biomarkers could improve treatment outcome prediction.
- Integrating microbial and human genomes offers a more comprehensive view of drug response.
- The dynamic nature of the microbiome presents opportunities for therapeutic interventions.
Outlook:
- Further research in human and animal models is needed to understand microbiome-drug interactions.
- Developing microbiome-based biomarkers is crucial for personalized medicine.
- Modulating the microbiome through diet or other interventions may enhance patient care.
Related Concept Videos
Introduction to the Human Microbiota
Development of Human Microbiota
The Skin Microbiota
Microbiome of the Eye
The Oral Microbiota
Functions of the Gut Microbiota

